相关临床试验
2
1 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
进行中（未招募）
1
50.0%
招募中
1
50.0%
暂无批准数据
- Adelaide University researchers led by Professor Ivan Kempson received $240,000 from the Mark Hughes Foundation Centre for Brain Cancer Research to study how radiation affects brain cancer at a cellular level. - The project uses first-of-their-kind tools in Australia to measure radiation-induced DNA damage with unprecedented precision, aiming to enhance tumor cell damage while protecting healthy tissue. - The team is also investigating how radiation influences the immune system, working with clinicians at the Royal Adelaide Hospital in a real-world treatment environment. - Brain cancer survival rates have changed little in 35 years, with only two in 10 patients surviving beyond five years, underscoring the urgent need for improved treatment approaches.
- A systematic review published in Pediatric Allergy and Immunology found significant associations between ultra-processed food consumption and the development of allergies and asthma in children. - Ultra-processed foods now comprise over 50% of dietary energy intake in high-income countries, making their health impacts a critical public health concern. - Research demonstrates that ultra-processed foods alter the gut microbiome and cause immune dysregulation, potentially explaining their connection to respiratory diseases. - Socioeconomic disparities limit access to fresh, healthy foods in low-income areas, contributing to higher rates of metabolic dysfunction and respiratory conditions like asthma.
• Pharmacy-led trials in NSW, Australia, have successfully expanded healthcare access for uncomplicated UTIs, allowing trained pharmacists to manage and treat the condition. • A trial resupplying oral contraceptives through pharmacies has shown positive feedback, leading to an expansion of patient age eligibility from 18-35 to 18-49 years. • Dermatology trials have commenced, enabling pharmacists to provide consultations and treatments for skin conditions like impetigo, herpes zoster, mild atopic dermatitis, and mild plaque psoriasis. • These trials aim to improve healthcare accessibility and inform policy decisions, emphasizing collaboration between pharmacists and general practitioners for optimized patient care.
